Myositis Flare vs Steroid Myopathy — SCE Rheumatology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: D — Manage as an active dermatomyositis flare and promptly intensify glucocorticoid and immunosuppressive treatment
The marked CK rise, recurrent symmetrical proximal weakness and return of Gottron papules indicate an active dermatomyositis flare. She therefore requires prompt escalation of glucocorticoid-based treatment and review or intensification of steroid-sparing immunosuppression. Glucocorticoid myopathy can cause painless proximal weakness, but it is non-inflammatory, usually develops insidiously and typically has a normal CK; it cannot explain the recurrent characteristic rash. Azathioprine is used as a steroid-sparing treatment for myositis and is not the likely cause of this clinicobiochemical pattern. EMG or muscle MRI may help when disease activity is uncertain, but delaying treatment for confirmatory testing is inappropriate here. Thyroid dysfunction remains a differential for weakness and CK elevation but would not account for the recurrent Gottron papules.
Reference: Oldroyd AGS et al. British Society for Rheumatology guideline on management of paediatric, adolescent and adult patients with idiopathic inflammatory myopathy. Rheumatology. 2022;61:1760–1768. https://www.rheumatology.org.uk/guidelines